| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PLoSO..1039251C |
| P356 | DOI | 10.1371/JOURNAL.PONE.0139251 |
| P932 | PMC publication ID | 4583228 |
| P698 | PubMed publication ID | 26406237 |
| P5875 | ResearchGate publication ID | 282278056 |
| P50 | author | Won-Jung Koh | Q60960471 |
| Sung Jae Shin | Q63865595 | ||
| P2093 | author name string | Sang-Nae Cho | |
| Jong-Seok Kim | |||
| Woo Sik Kim | |||
| Bo Young Jeon | |||
| Seung Bin Cha | |||
| Kee Woong Kwon | |||
| Hong Min Kim | |||
| P2860 | cites work | Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent | Q28191546 |
| Susceptibility to nontuberculous mycobacterial lung disease | Q28282274 | ||
| Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries | Q28729217 | ||
| Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis | Q30480795 | ||
| Sensitivity of acid-fast staining for Mycobacterium tuberculosis in formalin-fixed tissue | Q31113062 | ||
| Reactivation of latent tuberculosis: variations on the Cornell murine model | Q34001719 | ||
| Efficient differentiation of Mycobacterium avium complex species and subspecies by use of five-target multiplex PCR. | Q34489594 | ||
| Host susceptibility factors in mycobacterial infection. Genetics and body morphotype | Q34579168 | ||
| Understanding latent tuberculosis: a moving target | Q35851626 | ||
| Recurrent Mycobacterium avium infection after seven years of latency in a HIV-infected patient receiving efficient antiretroviral therapy. | Q54330263 | ||
| Environmental Risk Factors for Infection with Mycobacterium avium Complex | Q58321661 | ||
| Characterization of virulence, colony morphotype and the glycopeptidolipid of Mycobacterium avium strain 104 | Q58518801 | ||
| The Intravenous Model of Murine Tuberculosis is Less Pathogenic Than the Aerogenic Model Owing to a More Rapid Induction of Systemic Immunity | Q58519081 | ||
| Nontuberculous mycobacterial sensitization in the United States: national trends over three decades | Q80346610 | ||
| The immunity and protective effects of antigen 85A and heat-shock protein X against progressive tuberculosis | Q82535314 | ||
| Mycobacterial diseases developed during anti-tumour necrosis factor-α therapy | Q87521589 | ||
| A model for analyzing growth kinetics of a slowly growing Mycobacterium sp. | Q36069783 | ||
| The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug | Q36263124 | ||
| Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy | Q36263128 | ||
| Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues | Q36268025 | ||
| Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease | Q36411147 | ||
| An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases | Q36727850 | ||
| Pulmonary non-tuberculous mycobacterial infections. | Q37757280 | ||
| Update on the epidemiology of pulmonary nontuberculous mycobacterial infections | Q38086454 | ||
| Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease | Q41664386 | ||
| Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice | Q41787405 | ||
| The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment | Q42717214 | ||
| Sequencing of hsp65 distinguishes among subsets of the Mycobacterium avium complex | Q43234412 | ||
| Mycobacterial diseases and antitumour necrosis factor therapy in USA. | Q43907152 | ||
| Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M avium complex lung disease | Q44638677 | ||
| Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report | Q45180236 | ||
| Mycobacterial infections in patients treated with tumor necrosis factor antagonists in South Korea | Q45387141 | ||
| Latent infection as a source of disseminated disease caused by organisms of the Mycobacterium avium complex in simian immunodeficiency virus-infected rhesus macaques. | Q45723590 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mycobacterium avium avium | Q310728 |
| murine model | Q122890741 | ||
| P304 | page(s) | e0139251 | |
| P577 | publication date | 2015-09-25 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Experimental Reactivation of Pulmonary Mycobacterium avium Complex Infection in a Modified Cornell-Like Murine Model | |
| P478 | volume | 10 |
| Q64079920 | Infection in a C3HeB/FeJ Mouse Model |
| Q37746200 | Rv2299c, a novel dendritic cell-activating antigen of Mycobacterium tuberculosis, fused-ESAT-6 subunit vaccine confers improved and durable protection against the hypervirulent strain HN878 in mice. |
| Q64243683 | The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases |
Search more.